GSE226525 GSE226527 HNRNPH2 knockout 4 v 8 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE226525_GSE226527_HNRNPH2 knockout_4_v_8_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE226525_GSE226527_HNRNPH2 knockout_4_v_8_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE226525_GSE226527_HNRNPH2 knockout_4_v_8_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE226525_GSE226527_HNRNPH2 knockout_4_v_8_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

carbonic anhydrase 2

Gene

C-X-C motif chemokine ligand 14

Gene

heme oxygenase 1

Gene

eukaryotic translation initiation factor 5A

Gene

cell division cycle 20

Gene

dickkopf Wnt signaling pathway inhibitor 1

Gene

metallothionein 1E

Gene

3-hydroxy-3-methylglutaryl-CoA synthase 1

Gene

stearoyl-CoA desaturase

Gene

fibroblast growth factor receptor 3

  • Gene

    carbonic anhydrase 2


  • Gene

    C-X-C motif chemokine ligand 14


  • Gene

    heme oxygenase 1


  • Gene

    eukaryotic translation initiation factor 5A


  • Gene

    cell division cycle 20


  • Gene

    dickkopf Wnt signaling pathway inhibitor 1


  • Gene

    metallothionein 1E


  • Gene

    3-hydroxy-3-methylglutaryl-CoA synthase 1


  • Gene

    stearoyl-CoA desaturase


  • Gene

    fibroblast growth factor receptor 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.